Holen Sie sich die Stockscreener-App
1.81
5.24%
-0.10
Handel nachbörslich:
1.84
0.03
+1.66%
Schlusskurs vom Vortag:
$1.91
Offen:
$1.89
24-Stunden-Volumen:
1.69M
Relative Volume:
1.62
Marktkapitalisierung:
$196.08M
Einnahmen:
$27.08M
Nettoeinkommen (Verlust:
$-37.00M
KGV:
-3.4808
EPS:
-0.52
Netto-Cashflow:
$-18.46M
1W Leistung:
-1.63%
1M Leistung:
-7.18%
6M Leistung:
+53.39%
1J Leistung:
+50.83%
1-Tages-Spanne:
$1.74
$1.89
1-Wochen-Bereich:
$1.74
$1.97
52-Wochen-Spanne:
$1.05
$5.17
Aclaris Therapeutics Inc Stock (ACRS) Company Profile
Firmenname
Aclaris Therapeutics Inc
Sektor
Branche
Telefon
484-324-7933
Adresse
701 LEE ROAD, WAYNE, PA
Vergleichen Sie ACRS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACRS
Aclaris Therapeutics Inc
|
1.81 | 206.91M | 27.08M | -37.00M | -18.46M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Aclaris Therapeutics Inc Stock (ACRS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-05-28 | Eingeleitet | Wedbush | Outperform |
| 2025-03-18 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2024-12-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-11-20 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-11-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-11-19 | Hochstufung | Jefferies | Hold → Buy |
| 2024-11-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-11-18 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-01-22 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-10-03 | Eingeleitet | Evercore ISI | Outperform |
| 2022-12-14 | Eingeleitet | Stifel | Buy |
| 2022-12-01 | Eingeleitet | Goldman | Buy |
| 2022-10-06 | Eingeleitet | BTIG Research | Buy |
| 2021-07-23 | Fortgesetzt | Jefferies | Buy |
| 2021-06-15 | Eingeleitet | Piper Sandler | Overweight |
| 2021-04-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-10-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-09-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-27 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-05-06 | Eingeleitet | SVB Leerink | Outperform |
| 2018-03-28 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-02-09 | Eingeleitet | Guggenheim | Buy |
| 2017-06-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2016-11-29 | Eingeleitet | Leerink Partners | Outperform |
| 2016-09-30 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-06-10 | Eingeleitet | Guggenheim | Buy |
| 2015-11-02 | Eingeleitet | Citigroup | Buy |
| 2015-11-02 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Aclaris Therapeutics Inc Aktie (ACRS) Neueste Nachrichten
Aclaris Therapeutics, Inc. Hosts R&D Day Highlighting Therapeutic Innovations - TradingView
How Aclaris Therapeutics Inc. stock trades before earningsJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com
Will Aclaris Therapeutics Inc. stock outperform Dow Jones index2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Published on: 2025-10-14 03:19:57 - newser.com
Full technical analysis of Aclaris Therapeutics Inc. stockTrade Risk Assessment & AI Based Buy/Sell Signal Reports - newser.com
Why Aclaris Therapeutics Inc. stock attracts global investorsJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
What high frequency data says about Aclaris Therapeutics Inc.July 2025 PostEarnings & Consistent Return Investment Signals - newser.com
Using data models to predict Aclaris Therapeutics Inc. stock movementDip Buying & Intraday High Probability Setup Alerts - newser.com
Using Python tools to backtest Aclaris Therapeutics Inc. strategiesJuly 2025 Gainers & Growth Focused Entry Reports - newser.com
Will Aclaris Therapeutics Inc. stock outperform international peersAnalyst Downgrade & Community Verified Watchlist Alerts - newser.com
Applying Elliott Wave Theory to Aclaris Therapeutics Inc.Weekly Investment Summary & Fast Exit and Entry Trade Guides - newser.com
Is Aclaris Therapeutics (NASDAQ:ACRS) In A Good Position To Invest In Growth? - Yahoo Finance
Building trade automation scripts for Aclaris Therapeutics Inc.2025 Trade Ideas & Weekly Momentum Picks - newser.com
Real time alert setup for Aclaris Therapeutics Inc. performanceQuarterly Portfolio Review & Fast Exit and Entry Trade Guides - newser.com
Real time breakdown of Aclaris Therapeutics Inc. stock performanceJuly 2025 Technicals & Fast Exit and Entry Trade Guides - newser.com
Is Aclaris Therapeutics Inc. (8AT) stock testing key supportGDP Growth & Stock Portfolio Risk Control - newser.com
Atopic Dermatitis Pipeline Outlook Report 2025: Insight into emerging drugs, treatment options, clinical trials, and company strategies - The Globe and Mail
What analysts say about Aclaris Therapeutics Inc 8AT stockMarket Sentiment Shifts & Outperform the Market with Aggressive Picks - earlytimes.in
How Aclaris Therapeutics Inc. stock performs during Fed tightening cyclesEarnings Recap Report & Weekly Top Gainers Alerts - newser.com
Sentiment analysis tools applied to Aclaris Therapeutics Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Will Aclaris Therapeutics Inc. rebound enough to break evenRate Cut & High Accuracy Trade Signal Alerts - newser.com
Risk vs reward if holding onto Aclaris Therapeutics Inc.July 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Real time scanner hits for Aclaris Therapeutics Inc. explainedCEO Change & Daily Stock Trend Reports - newser.com
Will Aclaris Therapeutics Inc. (8AT) stock profit from automation waveGold Moves & High Yield Equity Trading Tips - newser.com
Aclaris to Host 2025 R&D Day in New York to Spotlight Immuno-Inflammatory Pipeline - MyChesCo
Using Bollinger Bands to evaluate Aclaris Therapeutics Inc.July 2025 PostEarnings & High Yield Stock Recommendations - newser.com
How high can Aclaris Therapeutics Inc. stock goCPI Data & Free Community Supported Trade Ideas - newser.com
Will Aclaris Therapeutics Inc. (8AT) stock beat revenue estimatesWeekly Trade Review & Accurate Intraday Trade Tips - newser.com
Published on: 2025-10-02 23:56:18 - newser.com
Finanzdaten der Aclaris Therapeutics Inc-Aktie (ACRS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aclaris Therapeutics Inc-Aktie (ACRS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mehra Anand | Director |
Nov 19 '24 |
Buy |
2.25 |
666,666 |
1,499,998 |
710,030 |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):